Inscription Capital’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Hold
3,767
0.11% 181
2025
Q4
$1.08M Buy
3,767
+34
+0.9% +$9.5K 0.11% 174
2025
Q3
$969K Hold
3,733
0.1% 199
2025
Q2
$927K Buy
3,733
+17
+0.5% +$4.2K 0.13% 116
2025
Q1
$1.01M Buy
+3,716
New +$990K 0.17% 102
2024
Q3
$1.05M Hold
3,708
0.16% 106
2024
Q2
$986K Sell
3,708
-8
-0.2% -$2.1K 0.16% 104
2024
Q1
$1.01M Hold
3,716
0.17% 102
2023
Q4
$932K Hold
3,716
0.25% 71
2023
Q3
$874K Sell
3,716
-235
-6% -$57.3K 0.28% 65
2023
Q2
$967K Hold
3,951
0.3% 62
2023
Q1
$942K Hold
3,951
0.25% 76
2022
Q4
$980K Hold
3,951
0.34% 71
2022
Q3
$884K Hold
3,951
0.25% 69
2022
Q2
$930K Hold
3,951
0.17% 99
2022
Q1
$1M Hold
3,951
0.29% 74
2021
Q4
$1.05M Buy
3,951
+1,392
+54% +$355K 0.29% 76
2021
Q3
$635K Sell
2,559
-9,050
-78% -$2.32M 0.2% 103
2021
Q2
$2.87M Buy
+11,609
New +$2.77M 0.33% 68

Other funds holding VHT

Inscription Capital's VHT Position: Q1 2026 in Review

Inscription Capital held its Vanguard Health Care ETF (VHT) position steady in Q1 2026 at 3,767 shares worth $1.03M. The position accounts for 0.11% of the portfolio, ranked #181.

Inscription Capital first reported a position in VHT in Q2 2021 and has held it in 19 quarters since. The position peaked at $2.87M in Q2 2021. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • Inscription Capital held 3,767 shares of Vanguard Health Care ETF worth $1.03M as of Q1 2026.
  • Inscription Capital left its Vanguard Health Care ETF share count unchanged in Q1 2026.
  • Vanguard Health Care ETF made up 0.11% of Inscription Capital's portfolio in Q1 2026, its #181 holding.
  • Inscription Capital first reported a position in Vanguard Health Care ETF in Q2 2021 and has held it in 19 quarters since.
  • Inscription Capital's Vanguard Health Care ETF position peaked at $2.87M in Q2 2021.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.